AMYT

Amryt Pharma (AMYT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AMYT
DataOraFonteTitoloSimboloCompagnia
11/01/202215:39Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma delists from AIM as trading shifts to New YorkLSE:AMYTAmryt Pharma Plc
06/01/202218:29UK RegulatoryFTSE Russell Amryt PharmaLSE:AMYTAmryt Pharma Plc
06/01/202208:00UK RegulatoryAmryt Pharma plc Key Dates For Aim DelistingLSE:AMYTAmryt Pharma Plc
04/01/202213:00UK RegulatoryAmryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly PatientsLSE:AMYTAmryt Pharma Plc
04/01/202208:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
30/11/202108:00UK RegulatoryAmryt Pharma plc Director/Pdmr ShareholdingLSE:AMYTAmryt Pharma Plc
23/11/202114:21Dow Jones NewsAmryt Pharma Says FDA Extends Oleogel-S10 New Drug Application Review by Three MonthsLSE:AMYTAmryt Pharma Plc
23/11/202113:00UK RegulatoryAmryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10LSE:AMYTAmryt Pharma Plc
22/11/202108:00UK RegulatoryAmryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On AimLSE:AMYTAmryt Pharma Plc
09/11/202123:01Alliance NewsAlliance NewsTRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pillLSE:AMYTAmryt Pharma Plc
03/11/202112:00UK RegulatoryAmryt Pharma plc Amryt Reports Strong Q3 2021 ResultsLSE:AMYTAmryt Pharma Plc
01/11/202108:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Acromegaly Awareness DayLSE:AMYTAmryt Pharma Plc
22/10/202108:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global EB Awareness Week 2021LSE:AMYTAmryt Pharma Plc
20/10/202113:00UK RegulatoryAmryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3LSE:AMYTAmryt Pharma Plc
19/10/202113:00UK RegulatoryAmryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)LSE:AMYTAmryt Pharma Plc
23/09/202112:59RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global FH Awareness DayLSE:AMYTAmryt Pharma Plc
14/09/202108:32Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisitionLSE:AMYTAmryt Pharma Plc
13/09/202113:00UK RegulatoryAmryt Pharma plc Amryt Raises Full Year 2021 Revenue Guidance To $220m - $225mLSE:AMYTAmryt Pharma Plc
19/08/202108:00UK RegulatoryAmryt Pharma plc Amryt Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
13/08/202114:23UK RegulatoryAmryt Pharma PLC Holding(s) in Company - ReplacementLSE:AMYTAmryt Pharma Plc
11/08/202112:30UK RegulatoryAmryt Pharma PLC Holdings in CompanyLSE:AMYTAmryt Pharma Plc
11/08/202111:36UK RegulatoryAmryt Pharma PLC Holding(s) in CompanyLSE:AMYTAmryt Pharma Plc
09/08/202113:00UK RegulatoryAmryt Pharma plc Amryt Virtual Capital Markets Event - September 13, 2021 -- 1000-1200 EdtLSE:AMYTAmryt Pharma Plc
06/08/202115:41Alliance NewsAlliance NewsIN BRIEF: Amryt hikes guidance on record second quarter resultsLSE:AMYTAmryt Pharma Plc
06/08/202113:00UK RegulatoryAmryt Pharma plc Amryt Reports Record Q2 2021 Results And Raises Fy 2021 GuidanceLSE:AMYTAmryt Pharma Plc
05/08/202116:50UK RegulatoryAmryt Pharma plc Amryt Successfully Completes Acquisition Of Chiasma, Inc., Board Appointments, Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
28/07/202116:00UK RegulatoryAmryt Pharma plc Result Of General MeetingsLSE:AMYTAmryt Pharma Plc
12/07/202113:00UK RegulatoryAmryt Pharma plc Amryt To Report Q2 2021 Results And Host Conference Call & Webcast On August 6LSE:AMYTAmryt Pharma Plc
28/06/202113:00UK RegulatoryAmryt Pharma plc Publication Of Circular To Amryt Shareholders In Relation To The Acquisition Of Chiasma, Inc., And Posting O...LSE:AMYTAmryt Pharma Plc
15/06/202112:45UK RegulatoryAmryt Pharma plc Amryt Pharma Announces Filing Of Preliminary Registration Statement On Form F-4 In Connection With Its Propo...LSE:AMYTAmryt Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AMYT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network